Notification of decision to issue a licence on application - posted 19 August 2010
PDF 42 KB
HTML

Questions & Answers
PDF 19 KB
HTML

Risk Assessment and Risk Management Plan (RARMP) Executive Summary
PDF 42 KB
HTML

Risk Assessment and Risk Management Plan (RARMP) Technical Summary
PDF 51 KB
HTML

Full Risk Assessment and Risk Management Plan (RARMP) for the commercial release of a genetically modified live viral vaccine to protect against Japanese Encephalitis (IMOJEV®)
PDF 669 KB
HTML

Licence application summary
PDF 68 KB
HTML

GM Vaccine Licence Conditions
PDF 269 KB
HTML


Reference Material

Risk Analysis Framework for Licence Applications to the Office of the Gene Technology Regulator (3rd Edition) 2009